Markers of Heart, Lung and Dorsal Aorta Damage of Mother Rats and Their Neonates Post Therapeutic Treatment with Doxorubicin, Cisplatin and 5-Flurouracil
Aim: Recently, there is an increased average of developing cancers. Though,
the chemotherapeutic-treatment is unfavorable during pregnancy due to its
harmful effects on developing fetuses, physicians have two ways to minimize
these effects either by termination of the pregnancy or minimizing its side effects.
The present work aimed to illustrate the susceptibility of cardiac, lung and
dorsal aorta function to the widely applicable drugs doxorubicin and cisplatin
as well as 5-flurouracil. Materials and Methods: Mother albino rats were
arranged into four-groups (control, doxorubicin, cisplatin and 5-flurouracil-treated
groups). Each pregnant rat received intraperitoneal administration of 0.2 mg/kg
body weight at 10th and 14th day of gestation and
sacrificed at parturition (two doses). At parturition, serum of mother rats
used to assess troponin I, heat shock protein 70, 8-hydroxydeoxyguanosine,
vascular endothelial growth factor and adhesion molecules (ICAM-1 & VCAM-1).
Isoenzyme electrophoresis of alkaline and acid phosphatases, glucose-6-phosphate
dehydrogenase and lactic dehydrogenase were estimated in serum, myocardium and
dorsal aorta of mother rats. The myocardium and lung were processed for histopathological
investigations for both mothers and their offspring. Single strand (comet
assay) and double strand DNA damage were carried out in heart and dorsal aorta
of mother rats. Results: The present finding revealed that there are
detected alterations of myocardial markers and lung amino acid metabolism as
well as disruption of myocardial isoenzymes. DNA damage of myocardium and
dorsal aorta were observed. Conclusions: The authors concluded that the
metabolic activity of heart and lung is highly susceptible to doxorubicin and
cisplatin treatment compared to 5-flurouracil and the therapeutic doses must be
degraded.
References
[1]
Stensheim, H., Moller, B., van Dijk, T. and Fossa, S.D. (2009) Cause-Specific Survival for Women Diagnosed with Cancer during Pregnancy or Lactation: A Registry Based Cohort Study. Journal Clinical Oncology, 27, 45-51.
https://doi.org/10.1200/JCO.2008.17.4110
[2]
Cardonick, E.H., Gringlas, M.B., Hunter, K. and Greenspan, J. (2015) Development of Children Born to Mothers with Cancer during Pregnancy: Comparing in Utero Chemotherapy-Exposed Children with Nonexposed Controls. American Journal Obstetric Gynecology, 212, 651-658. https://doi.org/10.1016/j.ajog.2014.11.032
[3]
Scavuzzo, A., Santana Rios, Z., Diaz-Gomez, C., Varguez Gonzalez, B., Osornio-Sanchez, V., Bravo-Castro, E., Linden-Castro, E., Martinez-Cervera, P. and Jimenez-Rios, M.A. (2017) Renal Cell Carcinoma in a Pregnant Woman With Horseshoe Kidney. Urology Case Report, 13, 58-60.
https://doi.org/10.1016/j.eucr.2015.11.004
[4]
Boudy, A.S., Naoura, I., Zilberman, S., Gligorov, J., Chabbert-Buffet, N., Ballester, M., Selleret, L. and Darai, E. (2017) Clues to Differentiate Pregnancy-Associated Breast Cancer from Those Diagnosed in Postpartum Period: A Monocentric Experience of Pregnancy-Associated Cancer Network (CALG). Bulletin Cancer, 104, 574-584. https://doi.org/10.1016/j.bulcan.2017.03.012
[5]
Pinnix, C.C., Andraos, T., Milgrom, S. and Fanale, M.A. (2017) The Management of Lymphoma in the Setting of Pregnancy. Current Hematologic Malignancy Reports 12, 251-256. https://doi.org/10.1007/s11899-017-0386-x
[6]
Gwyn, K. (2005) Children Exposed to Chemotherapy in Utero. Journal National Cancer Institute, 34, 69-71. https://doi.org/10.1093/jncimonographs/lgi009
[7]
Monteiro, D.L., Trajano, A.J., Menezes, D.C., Silveira, N.L., Magalhaes, A.C., Miranda, F.R. and Caldas, B. (2013) Breast Cancer during Pregnancy and Chemotherapy: A Systematic Review. Revista Da Associacao Medica Brasileira, 59, 174-180.
https://doi.org/10.1016/j.ramb.2012.10.003
[8]
Di Lisi, D., Madonna, R., Zito, C., Bronte, E., Badalamenti, G., Parrella, P., Monte, I., Tocchetti, C.G., Russo, A. and Novo, G. (2017) Anticancer Therapy-Induced Vascular Toxicity: VEGF Inhibition and Beyond. International Journal Cardiology, 227, 11-17. https://doi.org/10.1016/j.ijcard.2016.11.174
[9]
Drake, K.J., Sidorov, V.Y., McGuinness, O.P., Wasserman, D.H. and Wikswo, J.P. (2012) Amino Acids as Metabolic Substrates during Cardiac Ischemia. Experimental Biology and Medicine, 237, 1369-1378. https://doi.org/10.1258/ebm.2012.012025
[10]
Barker, D.J. (2001) In Fetal Origins of Cardiovascular and Lung Disease. CRC Press, Boca Raton, 398 p.
[11]
Warner, J.O. and Jones, C.A. (2001) Fetal Origins of Lung Disease. In: Barker, D.J.P., Ed., Fetal Origins of Cardiovascular and Lung Disease, Dekker, New York, 297-321.
[12]
Xu, Q., Willeit, J., Marosi, M., Kleindienst, R., Oberhollenzer, F., Kiechl, S., Stulnig, T., Luef, G. and Wick, G. (1993) Association of Serum Antibodies to Heat-Shock Protein 65 with Carotid Atherosclerosis. Lancet, 341, 255-259.
https://doi.org/10.1016/0140-6736(93)92613-X
[13]
Attia, S. (2012) Modulation of Irinotecan-Induced Genomic DNA Damage by Theanine. Food Chemical Toxicology, 50, 1749-1754.
https://doi.org/10.1016/j.fct.2012.02.092
[14]
Laemmli, U.K. (1970) Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature, 227, 680-685. https://doi.org/10.1038/227680a0
[15]
Lowry, O.H., Rosehmugh, N.J., Farr, A.L. and Randall, K.J. (1951) Protein Measurement with the Folin Phenol Reagent. Journal Biological Chemistry, 193, 265-275.
[16]
Andrews, A.T. (1986) Electrophoresis: Theory, Techniques and Biochemical and Clinical Applications. 2nd Edition, Oxford University Press, New York.
[17]
Warnes, T.W., Hine, P. and Kay, G. (1977) Intestinal Alkaline Phosphatase in the Diagnosis of Liver Disease. Gut, 18, 274-278. https://doi.org/10.1136/gut.18.4.274
[18]
Foti, A.G., Herschman, H.J. and Cooper, J.F. (1977) Isozymes of Acid Phosphatase in Normal and Cancerous Human Prostatic Tissue. Cancer Research, 37, 4120-4124.
[19]
Gaal, O., Medgyesi, G.A. and Vereczkey, L. (1980) Electrophoresis in the Separation of Biological Macromolecules. John Wiley & Sons, Chichester, 83-87.
[20]
Lehnert, T. and Berlet, H.H. (1979) Selective Inactivation of Lactate Dehydrogenase of Rat Tissues by Sodium Deoxycholate. Biochemical Journal, 177, 813-818.
[21]
Niece, R.L., Ericsson, L.H., Fowler, A.V., Smith, A.J., Speicher, D.W., Crabb, J.W. and Williams, K.R. (1991) Amino Acid Analysis and Sequencing: What Is State-of-the-Art? In: Jornvall, H., Hoog, J.-O. and Gustavsson, A.-M., Eds., Methods in Protein Sequence Analysis Basel, Birkhauser Verlag, Switzerland.
https://doi.org/10.1042/bj1770813
[22]
Sasaki, Y.F., Nishidate, E., Izumiyama, F., Matsusaka, N. and Tsuda, S. (1997) Simple Detection of Chemical Mutagens by the Alkaline Singlecell Gel Electrophoresis (Comet) Assay in Multiple Mouse Organs (Liver, Lung, Spleen, Kidney, and Bone Marrow). Mutation Research, 391, 215-231.
https://doi.org/10.1016/S1383-5718(97)00073-9
[23]
Duke, R.C. and Sellins, K.S. (1989) Target Cell Nuclear Damage in Addition to DNA Fragmentation during Cytotoxic T Lymphocyte-Mediated Cytolysis. In: Kaplan, J.G., Green, D.R. and Bleackley, R.C., Eds., Cellular Basis of Immune Modulation, Alan R. Liss, Inc., New York, 311-314.
[24]
Lipshultz, S.E. (2006) Exposure to Anthracyclines during Childhood Causes Cardiac Injury. Seminars in Oncology, 33, S8-S14.
https://doi.org/10.1053/j.seminoncol.2006.04.019
[25]
Wang, J., He, D., Zhang, Q., Han, Y., Jin, S. and Qi, F. (2009) Resveratrol Protects against Cisplatin-Induced Cardiotoxicity by Alleviating Oxidative Damage. Cancer Biotherapy & Radiopharmaceuticals, 24, 675-680.
https://doi.org/10.1089/cbr.2009.0679
[26]
Kian, V., Gao, L., Quo, P., Zhao, Y. and Lin, T. (2016) Grape Seed Proanthocyanidins Extract Prevents Cisplatin-Induced Cardiotoxicity in Rats. Food Science Technology Research, 22, 403-408. https://doi.org/10.3136/fstr.22.403
[27]
Kosoko, A.M., Olurinde, O.J. and Akinloye, O.A. (2017) Doxorubicin Induced Neuro- and Cardiotoxicity in Experimental Rats: Protection against Oxidative Damage by Theobroma Cacao Stem Bark. Biochemistry and Biophysics Reports, 10, 303-317. https://doi.org/10.1016/j.bbrep.2017.01.012
[28]
Kletzien, R.F., Harris, P.K. and Foellmi, L.A. (1994) Glucose-6-Phosphate Dehydrogenase: A “Housekeeping” Enzyme Subject to Tissue-Specific Regulation by Hormones, Nutrients, and Oxidant Stress. Federation of American Societies for Experimental Biology Journal, 8, 174-181.
[29]
Jain, M., Cui, L., Brenner, D.A., Wang, B., Handy, D.E., Leopold, J.A., Loscalzo, J., Apstein, C.S. and Liao, R. (2004) Increased Myocardial Dysfunction after Ischemia-Reperfusion in Mice Lacking Glucose-6-Phosphate Dehydrogenase. Circulation, 109, 898-903. https://doi.org/10.1161/01.CIR.0000112605.43318.CA
[30]
Leopold, J.A., Dam, A., Maron, B.A., Scribner, A.W., Liao, R., Handy, D.E., Stanton, R.C., Pitt, B. and Loscalzo, J. (2007) Aldosterone Impairs Vascular Reactivity by Decreasing Glucose-6-Phosphate Dehydrogenase Activity. Nature Medicine, 13, 189-197. https://doi.org/10.1038/nm1545
[31]
Surachetpong, S.D., Teewasutrakul, P. and Rungsipipat, A. (2016) Serial Measurements of Cardiac Troponin I (cTnI) in Dogs Treated with Doxorubicin. Japanese Journal Veterinary Research, 64, 221-233.
[32]
El-Awady, S.E., Moustafa, Y.M., Abo-Elmatty, D.M. and Radwan, A. (2011) Cisplatin-Induced Cardiotoxicity: Mechanisms and Cardioprotective Strategies. European Journal Pharmacology, 650, 335-341. https://doi.org/10.1016/j.ejphar.2010.09.085
[33]
Kroese, L.J. and Scheffer, P.G. (2014) 8-Hydroxy-2'-Deoxyguanosine and Cardiovascular Disease: A Systematic Review. Current Atherosclerosis Report, 16, 452.
https://doi.org/10.1007/s11883-014-0452-y
[34]
Frydman, J. (2001) Folding of Newly Translated Proteins in Vivo: The Role of Molecular Chaperones. Annual Review of Biochemistry, 70, 603-647.
https://doi.org/10.1146/annurev.biochem.70.1.603
[35]
Pratt, W.B. and Toft, D.O. (2003) Regulation of Signaling Protein Function and Trafficking by the Hsp90/Hsp70-Based Chaperone Machinery. Experimental Biology and Medicine, 228, 111-133. https://doi.org/10.1177/153537020322800201
[36]
Bry, M., Kivela, R., Leppanen, V.M. and Alitalo, K. (2014) Vascular Endothelial Growth Factor-B in Physiology and Disease. Physiological Review, 94, 779-794.
https://doi.org/10.1152/physrev.00028.2013
[37]
Kivela, R., Bry, M., Robciuc, M.R., Rasanen, M., Taavitsainen, M., Silvola, J.M., Saraste, A., Hulmi, J.J., Anisimov, A., Mayranpaa, M.I., Lindeman, J.H., Eklund, L., Hellberg, S., Hlushchuk, R., Zhuang, Z.W., Simons, M., Djonov, V., Knuuti, J., Mervaala, E. and Alitalo, K. (2014) VEGF-B-Induced Vascular Growth Leads to Metabolic Reprogramming and Ischemia Resistance in the Heart. EMBO Molecular Medicine, 6, 307-321. https://doi.org/10.1002/emmm.201303147
[38]
Robciuc, M.R., Kivela, R., Williams, I.M., de Boer, J.F., van Dijk, T.H., Elamaa, H., Tigistu-Sahle, F., Molotkov, D., Leppanen, V.M., Kakela, R., Eklund, L., Wasserman, D.H., Groen, A.K. and Alitalo, K. (2016) VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications. Cell Metabolism, 23, 712-724. https://doi.org/10.1016/j.cmet.2016.03.004
[39]
Abou El Hassan, M.A., Verheul, H.M., Jorna, A.S., Schalkwijk, C., van Bezu, J., van der Vijgh, W.J. and Bast, A. (2003) The New Cardioprotector Monohydroxyethylrutoside Protects against Doxorubicin-Induced Inflammatory Effects in vitro. British Journal Cancer, 89, 357-362. https://doi.org/10.1038/sj.bjc.6601022
[40]
Kim, H.J., Jang, S.H., Ryu, J.S., Lee, J.E., Kim, Y.C., Lee, M.K., Jang, T.W., Lee, S.Y., Nakamura, H., Nishikata, N., Mori, M., Noguchi, Y., Miyano, H. and Lee, K.Y. (2015) The Performance of a Novel Amino Acid Multivariate Index for Detecting Lung Cancer: A Case Control Study in Korea. Lung Cancer, 90, 522-527.
https://doi.org/10.1016/j.lungcan.2015.10.006
[41]
Forli, L., Pedersen, J.I., Bjortuft, Vatn, M., Kofstad, J. and Boe, J. (2000) Serum Amino Acids in Relation to Nutritional Status, Lung Function and Energy Intake in Patients with Advanced Pulmonary Disease. Respiratory Medicine, 94, 868-874.
https://doi.org/10.1053/rmed.2000.0830
[42]
Nagamori, S., Wiriyasermkul, P., Okuda, S., Kojima, N., Hari, Y., Kiyonaka, S., Mori, Y., Tominaga, H., Ohgaki, R. and Kanai, Y. (2016) Structure Activity Relations of Leucine Derivatives Reveal Critical Moieties for Cellular Uptake and Activation of mTORC1-Mediated Signaling. Amino Acids, 48, 1045-1058.
https://doi.org/10.1007/s00726-015-2158-z
[43]
Laplante, M. and Sabatini, D.M. (2012) mTOR Signaling in Growth Control and Disease. Cell, 149, 274-293. https://doi.org/10.1016/j.cell.2012.03.017
[44]
McDonald, S., Rubin, P., Phillips, T.L. and Marks, L.B. (1994) Injury to the Lung from Cancer Therapy: Clinical Syndromes, Measurable Endpoints, and Potential Scoring Systems. International Journal of Radiation Oncology, 31, 1187-1203.
https://doi.org/10.1016/0360-3016(94)00429-O
[45]
Tamby, M.C., Chanseaud, Y., Guillevin, L. and Mouthon, L. (2003) New Insights into the Pathogenesis of Systemic Sclerosis. Autoimmunity Reviews, 2, 152-157.
https://doi.org/10.1016/S1568-9972(03)00004-1
[46]
Tashkin, D.P., Elashoff, R., Clements, P.J., Roth, M.D., Furst, D.E., Silver, R.M., Goldin, J., Arriola, E., Strange, C., Bolster, M.B., Seibold, J.R., Riley, D.J., Hsu, V.M., Varga, J., Schraufnagel, D., Theodore, A., Simms, R., Wise, R., Wigley, F., White, B., Steen, V., Read, C., Mayes, M., Parsley, E., Mubarak, K., Connolly, M.K., Golden, J., Olman, M., Fessler, B., Rothfield, N., Metersky, M., Khanna, D., Li, N. and Li, G. (2007) Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease. American Journal of Respiratory and Critical Care Medicine, 176, 1026-1034. https://doi.org/10.1164/rccm.200702-326OC
[47]
Kolb, T.M. and Hassoun, P.M. (2012) Right Ventricular Dysfunction in Chronic Lung Disease. Cardiology Clinics, 30, 243-256.
https://doi.org/10.1016/j.ccl.2012.03.005
[48]
Bonini, M. and Fiorenzano, G. (2017) Exertional Dyspnoea in Interstitial Lung Diseases: The Clinical Utility of Cardiopulmonary Exercise Testing. European Respiratory Review, 26, pii: 160099. https://doi.org/10.1183/16000617.0099-2016
[49]
Li, L., Hu, B., Gong, S., Yu, Y., Dai, H. and Yan, J. (2016) Pulmonary Function and Arterial Stiffness in Chronic Heart Failure. BioMed Research International, 2016, Article ID: 5478394. https://doi.org/10.1155/2016/5478394
[50]
Ray, S.D., Patel, D., Wong, V. and Bagchi, D. (2000) In vivo Protection of DNA Damage Associated Apoptotic and Necrotic Cell Deaths during Acetaminophen-Induced Nephrotoxicity, Amiodarone-Induced Lung Toxicity and Doxorubicin-Induced Cardiotoxicity by a Novel IH636 Grape Seed Proanthocyanidin Extract. Research Communications in Molecular Pathology and Pharmacology, 107, 137-166.
[51]
Romanov, Y.A., Chervontseva, A.M., Savchenko, V.G. and Smirnov, V.N. (2007) Vascular Endothelium: Target or Victim of Cytostatic Therapy? Canadian Journal of Physiology and Pharmacology, 85, 396-403. https://doi.org/10.1139/Y07-045
[52]
Yamac, D., Elmas, C., Ozogul, C., Keskil. Z. and Dursun, A. (2006) Ultrastructural Damage in Vascular Endothelium in Rats Treated with Paclitaxel and Doxorubicin. Ultrastructural Patholology, 30, 103-110.
https://doi.org/10.1080/01913120500406335
[53]
Focaccetti, C., Bruno, A., Magnani, E., Bartolini, D., Principi, E., Dallaglio, K., Bucci, E.O., Finzi, G., Sessa, F., Noonan, D.M. and Albini, A. (2015) Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes. PLoS One, 10, e0115686.
https://doi.org/10.1371/journal.pone.0115686
[54]
Lamberti, M., Porto, S., Marra, M., Zappavigna, S., Grimaldi, A., Feola, D., Pesce, D., Naviglio, S., Spina, A., Sannolo, N. and Caraglia, M. (2012) 5-Fluorouracil Induces Apoptosis in Rat Cardiocytes through Intracellular Oxidative Stress. Journal Experimental Clinical Cancer Research, 31, 60.
https://doi.org/10.1186/1756-9966-31-60
[55]
Ranchoux, B., Meloche, J., Paulin, R., Boucherat, O., Provencher, S. and Bonnet, S. (2016) DNA Damage and Pulmonary Hypertension. International Journal Molecular Science, 17, 990. https://doi.org/10.3390/ijms17060990
[56]
Kankeu, C., Clarke, K., Passante, E. and Huber, H.J. (2017) Doxorubicin-Induced Chronic Dilated Cardiomyopathy—The Apoptosis Hypothesis Revisited. Journal Molecular Medicine, 95, 239-248. https://doi.org/10.1007/s00109-016-1494-0
